The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Respiratory Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
The global Respiratory Drugs market size is expected to reach US$ 64390 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Drugs in various end use industries. The expanding demands from the Hospitals, Ambulatory Care and Others,, are propelling Respiratory Drugs market. Asthma, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chronic Obstructive Pulmonary Disease segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Drugs covered in this report include FibroGen, Amgen, Dr. Reddy's Laboratories, Afferent Pharmaceuticals, Dainippon Sumitomo, Abbott, Horizon Pharma, Amgen and Pfizer, etc.
The global Respiratory Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
FibroGen
Amgen
Dr. Reddy's Laboratories
Afferent Pharmaceuticals
Dainippon Sumitomo
Abbott
Horizon Pharma
Amgen
Pfizer
Global Respiratory Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Drugs market, Segment by Type:
Asthma
Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis
Cystic Fibrosis
Global Respiratory Drugs market, by Application
Hospitals
Ambulatory Care
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Respiratory Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Respiratory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
The global Respiratory Drugs market size is expected to reach US$ 64390 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Drugs in various end use industries. The expanding demands from the Hospitals, Ambulatory Care and Others,, are propelling Respiratory Drugs market. Asthma, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chronic Obstructive Pulmonary Disease segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Drugs covered in this report include FibroGen, Amgen, Dr. Reddy's Laboratories, Afferent Pharmaceuticals, Dainippon Sumitomo, Abbott, Horizon Pharma, Amgen and Pfizer, etc.
The global Respiratory Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
FibroGen
Amgen
Dr. Reddy's Laboratories
Afferent Pharmaceuticals
Dainippon Sumitomo
Abbott
Horizon Pharma
Amgen
Pfizer
Global Respiratory Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Drugs market, Segment by Type:
Asthma
Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis
Cystic Fibrosis
Global Respiratory Drugs market, by Application
Hospitals
Ambulatory Care
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Respiratory Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Respiratory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Respiratory Drugs Market Overview
1.1 Respiratory Drugs Product Overview
1.2 Respiratory Drugs Market Segment by Type
1.2.1 Asthma
1.2.2 Chronic Obstructive Pulmonary Disease
1.2.3 Idiopathic Pulmonary Fibrosis
1.2.4 Cystic Fibrosis
1.3 Global Respiratory Drugs Market Size by Type
1.3.1 Global Respiratory Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Respiratory Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Respiratory Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Respiratory Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Respiratory Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Respiratory Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Respiratory Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Respiratory Drugs Sales Breakdown by Type (2018-2023)
2 Global Respiratory Drugs Market Competition by Company
2.1 Global Top Players by Respiratory Drugs Sales (2018-2023)
2.2 Global Top Players by Respiratory Drugs Revenue (2018-2023)
2.3 Global Top Players by Respiratory Drugs Price (2018-2023)
2.4 Global Top Manufacturers Respiratory Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Respiratory Drugs Market Competitive Situation and Trends
2.5.1 Respiratory Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Respiratory Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Respiratory Drugs Market
2.8 Key Manufacturers Respiratory Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Respiratory Drugs Status and Outlook by Region
3.1 Global Respiratory Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Respiratory Drugs Historic Market Size by Region
3.2.1 Global Respiratory Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Respiratory Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Respiratory Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Respiratory Drugs Forecasted Market Size by Region
3.3.1 Global Respiratory Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Respiratory Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Respiratory Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Respiratory Drugs by Application
4.1 Respiratory Drugs Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Care
4.1.3 Others
4.2 Global Respiratory Drugs Market Size by Application
4.2.1 Global Respiratory Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Respiratory Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Respiratory Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Respiratory Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Respiratory Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Respiratory Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Respiratory Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Respiratory Drugs Sales Breakdown by Application (2018-2023)
5 North America Respiratory Drugs by Country
5.1 North America Respiratory Drugs Historic Market Size by Country
5.1.1 North America Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Respiratory Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Respiratory Drugs Sales in Value by Country (2018-2023)
5.2 North America Respiratory Drugs Forecasted Market Size by Country
5.2.1 North America Respiratory Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Respiratory Drugs Sales in Value by Country (2024-2029)
6 Europe Respiratory Drugs by Country
6.1 Europe Respiratory Drugs Historic Market Size by Country
6.1.1 Europe Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Respiratory Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Respiratory Drugs Sales in Value by Country (2018-2023)
6.2 Europe Respiratory Drugs Forecasted Market Size by Country
6.2.1 Europe Respiratory Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Respiratory Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Respiratory Drugs by Region
7.1 Asia-Pacific Respiratory Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Respiratory Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Respiratory Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Respiratory Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Respiratory Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Respiratory Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Respiratory Drugs Sales in Value by Region (2024-2029)
8 Latin America Respiratory Drugs by Country
8.1 Latin America Respiratory Drugs Historic Market Size by Country
8.1.1 Latin America Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Respiratory Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Respiratory Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Respiratory Drugs Forecasted Market Size by Country
8.2.1 Latin America Respiratory Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Respiratory Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Respiratory Drugs by Country
9.1 Middle East and Africa Respiratory Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Respiratory Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Respiratory Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Respiratory Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Respiratory Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Respiratory Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Respiratory Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 FibroGen
10.1.1 FibroGen Company Information
10.1.2 FibroGen Introduction and Business Overview
10.1.3 FibroGen Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 FibroGen Respiratory Drugs Products Offered
10.1.5 FibroGen Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Amgen Respiratory Drugs Products Offered
10.2.5 Amgen Recent Development
10.3 Dr. Reddy's Laboratories
10.3.1 Dr. Reddy's Laboratories Company Information
10.3.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.3.3 Dr. Reddy's Laboratories Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Dr. Reddy's Laboratories Respiratory Drugs Products Offered
10.3.5 Dr. Reddy's Laboratories Recent Development
10.4 Afferent Pharmaceuticals
10.4.1 Afferent Pharmaceuticals Company Information
10.4.2 Afferent Pharmaceuticals Introduction and Business Overview
10.4.3 Afferent Pharmaceuticals Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Afferent Pharmaceuticals Respiratory Drugs Products Offered
10.4.5 Afferent Pharmaceuticals Recent Development
10.5 Dainippon Sumitomo
10.5.1 Dainippon Sumitomo Company Information
10.5.2 Dainippon Sumitomo Introduction and Business Overview
10.5.3 Dainippon Sumitomo Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Dainippon Sumitomo Respiratory Drugs Products Offered
10.5.5 Dainippon Sumitomo Recent Development
10.6 Abbott
10.6.1 Abbott Company Information
10.6.2 Abbott Introduction and Business Overview
10.6.3 Abbott Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Abbott Respiratory Drugs Products Offered
10.6.5 Abbott Recent Development
10.7 Horizon Pharma
10.7.1 Horizon Pharma Company Information
10.7.2 Horizon Pharma Introduction and Business Overview
10.7.3 Horizon Pharma Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Horizon Pharma Respiratory Drugs Products Offered
10.7.5 Horizon Pharma Recent Development
10.8 Amgen
10.8.1 Amgen Company Information
10.8.2 Amgen Introduction and Business Overview
10.8.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Amgen Respiratory Drugs Products Offered
10.8.5 Amgen Recent Development
10.9 Pfizer
10.9.1 Pfizer Company Information
10.9.2 Pfizer Introduction and Business Overview
10.9.3 Pfizer Respiratory Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Pfizer Respiratory Drugs Products Offered
10.9.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Respiratory Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Respiratory Drugs Industrial Chain Analysis
11.4 Respiratory Drugs Market Dynamics
11.4.1 Respiratory Drugs Industry Trends
11.4.2 Respiratory Drugs Market Drivers
11.4.3 Respiratory Drugs Market Challenges
11.4.4 Respiratory Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Respiratory Drugs Distributors
12.3 Respiratory Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
